搜索筛选:
搜索耗时4.2770秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
[期刊论文] 作者：Lei Zhou,Xiao-yan Pang,Xiang-yu Hou,Lu Liu,Zi-tao Guo,Xiao-yan Chen,
来源：中国药理学报（英文版） 年份：2020
An increasing number of drugs are metabolized by aldehyde oxidase (AOX),but AOX-mediated drug interactions are seldom reported due to the lack of appropriate in...
,Potential role of organic anion transporting polypeptide 1B1 (OATP1B1) in the selective hepatic upt
[期刊论文] 作者：Xiu-li LI,Zi-tao GUO,Ye-dong WANG,Xiao-yan CHEN,Jia LIU,Da-fang ZHONG,
来源：中国药理学报（英文版） 年份：2015
...
Furmonertinib(Alflutinib,AST2818)is a potential positive control drug comparable to rifampin for eva
[期刊论文] 作者：Ya-li Wu,Ya-ru Xue,Zi-tao Guo,Zhen-dong Chen,Xin-yu Ge,Da-fang Zhong,Xing-xing Diao,
来源：中国药理学报（英文版） 年份：2022
Furmonertinib(Alflutinib,AST2818),as a third-generation epidermal growth factor receptor inhibitor with an advanced efficacy and a relatively wide safety window,has been commercially launched in China recently.However,previous clinical stud......
[期刊论文] 作者：Xiao-yun Liu,Zi-tao Guo,Zhen-dong Chen,Yi-fan Zhang,Jia-lan Zhou,Yong Jiang,Qian-yu Zhao,Xing-xing Diao,
来源：中国药理学报（英文版） 年份：2020
Alflutinib (AST2818) is a third-generation epidermal growth factor receptor (EGFR) inhibitor that inhibits both EGFR-sensitive mutations and T790M mutations.Pre...
相关搜索：
